FDC Stock Overview
Manufactures and markets pharmaceutical products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
FDC Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹491.50 |
| 52 Week High | ₹658.85 |
| 52 Week Low | ₹391.05 |
| Beta | 0.27 |
| 1 Month Change | 0.71% |
| 3 Month Change | -12.80% |
| 1 Year Change | 25.40% |
| 3 Year Change | 69.22% |
| 5 Year Change | 135.45% |
| Change since IPO | 477.22% |
Recent News & Updates
Estimating The Fair Value Of FDC Limited (NSE:FDC)
Nov 08
Why We Think FDC Limited's (NSE:FDC) CEO Compensation Is Not Excessive At All
Sep 20Recent updates
Estimating The Fair Value Of FDC Limited (NSE:FDC)
Nov 08Why We Think FDC Limited's (NSE:FDC) CEO Compensation Is Not Excessive At All
Sep 20There's Reason For Concern Over FDC Limited's (NSE:FDC) Massive 30% Price Jump
Sep 13Here's Why We Think FDC (NSE:FDC) Might Deserve Your Attention Today
Aug 27There Is A Reason FDC Limited's (NSE:FDC) Price Is Undemanding
Jul 04FDC Limited's (NSE:FDC) Price Is Right But Growth Is Lacking
Mar 02Here's Why FDC Limited's (NSE:FDC) CEO May Have Their Pay Bumped Up
Sep 21FDC (NSE:FDC) Seems To Use Debt Quite Sensibly
Sep 15Here's Why FDC Limited's (NSE:FDC) CEO Compensation Is The Least Of Shareholders' Concerns
Sep 16A Look At The Intrinsic Value Of FDC Limited (NSE:FDC)
May 13Weak Statutory Earnings May Not Tell The Whole Story For FDC (NSE:FDC)
Nov 18Here's Why I Think FDC (NSE:FDC) Is An Interesting Stock
Aug 20FDC Limited (NSE:FDC) Just Recorded An Earnings Miss And Analysts Are Updating Their Numbers
May 29Here's Why We Think FDC (NSE:FDC) Is Well Worth Watching
Apr 30What Percentage Of FDC Limited (NSE:FDC) Shares Do Insiders Own?
Mar 11If You Had Bought FDC (NSE:FDC) Shares Five Years Ago You'd Have Earned 63% Returns
Feb 21Declining Stock and Solid Fundamentals: Is The Market Wrong About FDC Limited (NSE:FDC)?
Feb 06
With EPS Growth And More, FDC (NSE:FDC) Is Interesting
Jan 19FDC Limited (NSE:FDC) Has Got What It Takes To Be An Attractive Dividend Stock
Dec 29Could The FDC Limited (NSE:FDC) Ownership Structure Tell Us Something Useful?
Dec 08The FDC (NSE:FDC) Share Price Has Gained 79% And Shareholders Are Hoping For More
Nov 12Is FDC Limited's (NSE:FDC) Latest Stock Performance A Reflection Of Its Financial Health?
Oct 22Does FDC (NSE:FDC) Deserve A Spot On Your Watchlist?
Oct 01Estimating The Fair Value Of FDC Limited (NSE:FDC)
Sep 10What Kind Of Shareholders Hold The Majority In FDC Limited's (NSE:FDC) Shares?
Aug 20What You Can Learn From FDC Limited's (NSE:FDC) P/E
Jul 25Is FDC Limited's (NSE:FDC) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jul 07Shareholder Returns
| FDC | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.4% | 0.8% | -4.2% |
| 1Y | 25.4% | 39.7% | 19.1% |
Return vs Industry: FDC underperformed the Indian Pharmaceuticals industry which returned 39.7% over the past year.
Return vs Market: FDC exceeded the Indian Market which returned 19.1% over the past year.
Price Volatility
| FDC volatility | |
|---|---|
| FDC Average Weekly Movement | 4.3% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: FDC has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: FDC's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1936 | 6,659 | Nandan Chandavarkar | www.fdcindia.com |
FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names.
FDC Limited Fundamentals Summary
| FDC fundamental statistics | |
|---|---|
| Market cap | ₹79.98b |
| Earnings (TTM) | ₹3.17b |
| Revenue (TTM) | ₹20.72b |
25.3x
P/E Ratio3.9x
P/S RatioIs FDC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FDC income statement (TTM) | |
|---|---|
| Revenue | ₹20.72b |
| Cost of Revenue | ₹7.53b |
| Gross Profit | ₹13.20b |
| Other Expenses | ₹10.03b |
| Earnings | ₹3.17b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 19.45 |
| Gross Margin | 63.68% |
| Net Profit Margin | 15.28% |
| Debt/Equity Ratio | 0% |
How did FDC perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield26%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 05:45 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
FDC Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Centrum Broking Limited |
| Kameswari V. S. Chavali | FirstCall Research |